The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective
Purpose: To summarize the characteristics and trends of interest in retinoblastoma (Rb) in the last 50 years. Methods: The Web of Science Database was used to find all studies focused on Rb published from 1970 to 2018. The term “retinoblastoma” was used to search for the 100 most cited records. Resu...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Vision |
Subjects: | |
Online Access: | https://www.mdpi.com/2411-5150/7/2/33 |
_version_ | 1797592404731101184 |
---|---|
author | Rachel Shemesh Hunter Sandler Sarah Dichter Ido Didi Fabian Eedy Mezer Tamara Wygnanski-Jaffe |
author_facet | Rachel Shemesh Hunter Sandler Sarah Dichter Ido Didi Fabian Eedy Mezer Tamara Wygnanski-Jaffe |
author_sort | Rachel Shemesh |
collection | DOAJ |
description | Purpose: To summarize the characteristics and trends of interest in retinoblastoma (Rb) in the last 50 years. Methods: The Web of Science Database was used to find all studies focused on Rb published from 1970 to 2018. The term “retinoblastoma” was used to search for the 100 most cited records. Results: The mean number of citations was 153.55 ± 88.9. The majority were from the United States (US) (<i>n</i> = 68). Drs. Shields authored 38% of the papers. The number of citations per year was positively correlated with the number of authors, r = 0.26 (<i>p</i> = 0.008). The number of patients was significantly associated with the number of citations per year (<i>p</i> = 0.012). Although papers on radiotherapy were the most common, publications about intra-arterial chemotherapy (IAC) were associated with 88.3% more citations per year (<i>p</i> = 0.031) and papers on intravenous chemotherapy (IVC) were associated with 40.3% more citations per year (<i>p</i>= 0.04). Review and meta-analysis studies had a higher median of citations (10.5) than interventional (6.4) or observational (5.2) studies. Conclusions: This study compiles a comprehensive analysis of the most-cited articles on Rb. Studies with a higher number of citations per year were associated with IAC, which emphasizes the significance of the advances in Rb treatments that allow for the saving of eyes and vision as well as lives. Review studies had more citations than observational or interventional studies. More citations were associated with a larger number of authors or more reported patients per paper. These findings highlight the importance of collaborations to achieve relevant, high-quality research of Rb. |
first_indexed | 2024-03-11T01:50:33Z |
format | Article |
id | doaj.art-ee412e7d37124135ad6e9872d7fec26e |
institution | Directory Open Access Journal |
issn | 2411-5150 |
language | English |
last_indexed | 2024-03-11T01:50:33Z |
publishDate | 2023-04-01 |
publisher | MDPI AG |
record_format | Article |
series | Vision |
spelling | doaj.art-ee412e7d37124135ad6e9872d7fec26e2023-11-18T13:03:28ZengMDPI AGVision2411-51502023-04-01723310.3390/vision7020033The Most-Cited Articles on Retinoblastoma: A Fifty-Year PerspectiveRachel Shemesh0Hunter Sandler1Sarah Dichter2Ido Didi Fabian3Eedy Mezer4Tamara Wygnanski-Jaffe5Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, IsraelSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, IsraelRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, IsraelSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, IsraelRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, IsraelSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, IsraelPurpose: To summarize the characteristics and trends of interest in retinoblastoma (Rb) in the last 50 years. Methods: The Web of Science Database was used to find all studies focused on Rb published from 1970 to 2018. The term “retinoblastoma” was used to search for the 100 most cited records. Results: The mean number of citations was 153.55 ± 88.9. The majority were from the United States (US) (<i>n</i> = 68). Drs. Shields authored 38% of the papers. The number of citations per year was positively correlated with the number of authors, r = 0.26 (<i>p</i> = 0.008). The number of patients was significantly associated with the number of citations per year (<i>p</i> = 0.012). Although papers on radiotherapy were the most common, publications about intra-arterial chemotherapy (IAC) were associated with 88.3% more citations per year (<i>p</i> = 0.031) and papers on intravenous chemotherapy (IVC) were associated with 40.3% more citations per year (<i>p</i>= 0.04). Review and meta-analysis studies had a higher median of citations (10.5) than interventional (6.4) or observational (5.2) studies. Conclusions: This study compiles a comprehensive analysis of the most-cited articles on Rb. Studies with a higher number of citations per year were associated with IAC, which emphasizes the significance of the advances in Rb treatments that allow for the saving of eyes and vision as well as lives. Review studies had more citations than observational or interventional studies. More citations were associated with a larger number of authors or more reported patients per paper. These findings highlight the importance of collaborations to achieve relevant, high-quality research of Rb.https://www.mdpi.com/2411-5150/7/2/33retinoblastomabibliometricscitationstreatmentchemotherapy |
spellingShingle | Rachel Shemesh Hunter Sandler Sarah Dichter Ido Didi Fabian Eedy Mezer Tamara Wygnanski-Jaffe The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective Vision retinoblastoma bibliometrics citations treatment chemotherapy |
title | The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective |
title_full | The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective |
title_fullStr | The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective |
title_full_unstemmed | The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective |
title_short | The Most-Cited Articles on Retinoblastoma: A Fifty-Year Perspective |
title_sort | most cited articles on retinoblastoma a fifty year perspective |
topic | retinoblastoma bibliometrics citations treatment chemotherapy |
url | https://www.mdpi.com/2411-5150/7/2/33 |
work_keys_str_mv | AT rachelshemesh themostcitedarticlesonretinoblastomaafiftyyearperspective AT huntersandler themostcitedarticlesonretinoblastomaafiftyyearperspective AT sarahdichter themostcitedarticlesonretinoblastomaafiftyyearperspective AT idodidifabian themostcitedarticlesonretinoblastomaafiftyyearperspective AT eedymezer themostcitedarticlesonretinoblastomaafiftyyearperspective AT tamarawygnanskijaffe themostcitedarticlesonretinoblastomaafiftyyearperspective AT rachelshemesh mostcitedarticlesonretinoblastomaafiftyyearperspective AT huntersandler mostcitedarticlesonretinoblastomaafiftyyearperspective AT sarahdichter mostcitedarticlesonretinoblastomaafiftyyearperspective AT idodidifabian mostcitedarticlesonretinoblastomaafiftyyearperspective AT eedymezer mostcitedarticlesonretinoblastomaafiftyyearperspective AT tamarawygnanskijaffe mostcitedarticlesonretinoblastomaafiftyyearperspective |